Go Pro

Gateway Wealth Partners LLC Sells 2,777 Shares of UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Gateway Wealth Partners reduced its UnitedHealth Group stake by 36.5% in the second quarter, selling 2,777 shares and retaining 4,832 shares valued at approximately $2.01 million. Institutional investors and hedge funds collectively own 87.86% of UNH.
  • UnitedHealth reported quarterly earnings of $6.38 per share, exceeding estimates of $4.94, while revenue reached $112.03 billion. The company issued fiscal 2026 EPS guidance of $19.50–$20.00.
  • Analysts maintain a generally positive view, with a consensus rating of “Moderate Buy” and an average price target of $455.92. UnitedHealth also declared a quarterly dividend of $2.32 per share, equivalent to a 2.3% annualized yield.
  • Interested in UnitedHealth Group? Here are five stocks we like better.

Gateway Wealth Partners LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 36.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,832 shares of the healthcare conglomerate's stock after selling 2,777 shares during the period. Gateway Wealth Partners LLC's holdings in UnitedHealth Group were worth $2,008,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Sarver Vrooman Wealth Advisors acquired a new position in UnitedHealth Group during the fourth quarter worth $25,000. Anfield Capital Management LLC increased its position in shares of UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Joseph Group Capital Management bought a new stake in UnitedHealth Group during the fourth quarter worth about $27,000. Nalls Sherbakoff Group LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $27,000. Finally, Lifetime Wealth Management P.C. bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $29,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 500 shares of the stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total value of $205,000.00. Following the transaction, the chief executive officer owned 16,497 shares of the company's stock, valued at approximately $6,763,770. This represents a 2.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.19% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $401.52 on Friday. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The business has a 50-day moving average price of $415.74 and a two-hundred day moving average price of $352.85. The company has a current ratio of 0.78, a quick ratio of 0.80 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $360.41 billion, a P/E ratio of 25.84, a P/E/G ratio of 1.40 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the previous year, the firm posted $4.08 earnings per share. UnitedHealth Group's revenue for the quarter was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group's payout ratio is 59.72%.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. Oppenheimer boosted their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the stock an "outperform" rating in a research note on Friday, July 17th. Leerink Partners upped their price target on shares of UnitedHealth Group from $400.00 to $462.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 17th. Barclays raised their price objective on shares of UnitedHealth Group from $429.00 to $441.00 and gave the company an "overweight" rating in a research report on Monday, July 20th. Weiss Ratings lowered shares of UnitedHealth Group from a "hold (c)" rating to a "hold (c-)" rating in a research report on Tuesday, July 28th. Finally, Wall Street Zen raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus target price of $455.92.

Read Our Latest Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines